We found that miR-129-5p was most strongly induced after Vemurafenib treatment in parental BRAF mutated melanoma cells, but not in the corresponding BRAFi resistant cells, normal melanocytes or BRAF wildtype melanoma cells. Here, BRAF is linked to melanoma.